Sunday, September 2, 2018

‘Price control, regulatory changes may hit pharma’

Economic outlook positive, but there are headwinds: Pfizer

from The Hindu - Industry https://ift.tt/2PqReJx
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)